Trial Profile
A Multicentre, Phase III, Double Blind Study of Photodynamic Therapy (PDT) With Metvix 160 mg/g Cream in Comparison to PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Feb 2021
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- Sponsors Galderma
- 06 Feb 2010 New trial record